A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression

Shunsuke Meike(Hokkaido University), Osamu Inanami(Hokkaido University), Akira Matsuda(Hokkaido University), Hironobu Yasui(Hokkaido University), Tohru Yamamori(Japan Space Forum), Yasundo Yamasaki(Taiho Pharmaceutical (Japan)), Masato Eitaki(Hokkaido University), Masakazu Fukushima(Taiho Pharmaceutical (Japan)), Masami Morimatsu(Hokkaido University)
Molecular Cancer
July 28, 2011
Cited by 23


Related Papers